Atlas Trials

US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector

Clinical trial NCT04356339 · COMPLETED

Trial details

NCT number
NCT04356339
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2020-11-24
Primary completion
2021-08-29
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.